CSIMarket Company Name, Ticker, Customers, else..
 

Ptc Therapeutics inc   (NASDAQ: PTCT)

Ptc Therapeutics Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

PTCT Sales vs. its Competitors Q1 2026


Comparing the current results to its competitors, Ptc Therapeutics Inc reported Revenue decrease in the 1 quarter 2026 year on year by -76.83 %, despite the revenue increase by the most of its competitors of 6.58 %, recorded in the same quarter.

• List of PTCT Competitors





Revenue Growth Comparisons




Net Income Comparison

Ptc Therapeutics inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 64.43 %

<<  PTCT Stock Performance Comparisons





  

Overall company Market Share Q1 2026
Overall company, revenue fell by -76.83 % and company lost market share, to approximately 0.45 %.




<<  More on PTCT Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Ptc Therapeutics inc




Enanta Pharmaceuticals Inc
Share Performance



+3.53%
Over The Past 5 Days
Enanta Pharmaceuticals Inc
Profile

Enanta Pharmaceuticals Inc's business model focuses on the research, development, and commercialization of innovative small molecule drugs targeting viral infections and liver diseases.

More about Enanta Pharmaceuticals Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 409.587 mill. $ 65.258 mill. $ -63.230 mill.


Medicinova Inc
Share Performance



+26.36%
One Year
Medicinova Inc
Profile

Medicinova Inc operates under a biopharmaceutical business model, primarily focused on the development and commercialization of innovative therapeutics. They strive to identify promising drug candidates with the potential to address unmet medical needs and advance them through clinical trials. By leveraging their research capabilities, strategic partnerships, and licensing opportunities, Medicinova Inc aims to bring these novel treatments to market and improve patient outcomes.

More about Medicinova Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 80.231 mill. $ 0.920 mill. $ -10.753 mill.


Medicure Inc
Share Performance



0.00%
30 Days
Medicure Inc
Profile

Medicure Inc operates as a pharmaceutical company with a business model that focuses on the research, development, and commercialization of innovative cardiovascular and other specialty pharmaceuticals. They aim to address unmet medical needs, improve patient outcomes, and deliver value to healthcare providers and consumers.

More about Medicure Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 25.925 mill. $ -5.920 mill.


Mereo Biopharma Group Plc
Share Performance



-50.98%
This Year
Mereo Biopharma Group Plc
Profile

Mereo Biopharma Group Plc's business model focuses on the development and commercialization of innovative therapeutics for rare diseases.

More about Mereo Biopharma Group Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 200.891 mill. $ - mill. $ -28.099 mill.


Nektar Therapeutics
Share Performance



+70.87%
This Year
Nektar Therapeutics
Profile

Nektar Therapeutics operates under a business model focused on developing and commercializing innovative medicines. The company's approach involves utilizing its proprietary technology platforms to create novel therapeutic candidates and establish partnerships with pharmaceutical and biotechnology firms for clinical development and commercialization. Nektar Therapeutics aims to bring transformative therapies to market that address significant unmet medical needs.

More about Nektar Therapeutics's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,452.340 mill. $ 54.589 mill. $ -157.127 mill.

86 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Ptc Therapeutics inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Ptc Therapeutics inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.